NICE guidance on cannabis based medicinal products

The Faculty is pleased to note the timely publication of NICE Guidance NG144 on cannabis-based medicinal products. The Faculty agrees with the recommendations and supports the endorsement of proper research, for safety, efficacy and licencing. You can read the Faculty’s position statement on the medicinal use of cannabinoids in Pain Medicine here.